http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2631938-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_717b38da63f0f5162162211d3ba70bf5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate | 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2672f5e2f455fe4cf1866df8a7998df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bb17e86ea343fe454405f20e76350cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_920aa88762fe6a367b1e7a1227646921 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e008fac85b44197e99bb6161deaf679 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d5319721ee5d8bd396f0fea9d2db7b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f699b1e9151ad5731ac77677c334bc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e25a0851e41be0b459e9d3641e9f5d1 |
| publicationDate | 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2631938-C1 |
| titleOfInvention | A/swine/siberia/1sw/2016 swine influenza virus strain of h1n1-subtype for influenza virus diagnosis by hir and pcr and research of effectiveness of vaccines and anti-viral drugs in vitro and in vivo |
| abstract | FIELD: medicine. n SUBSTANCE: strain of A/swine/Siberia/1sw/2016 swine influenza virus of H1N1 subtype isolated from homogenate of porcine lung tissue in Western Siberia and deposited in the State Collection of Viruses on the basis of the Institute of Virology named after D.I. Ivanovsky FSUE "FNICEM named after N. F. Gamaleya "of the Ministry of Health of Russia under number 2803 is proposed. The proposed strain can be used to prepare an antigen-containing substrate and serum for serodiagnosis of the H1 subtype influenza in the hemagglutination inhibition reaction (HIR), and can also be used as a reference sample for test systems specificity evaluation by PCR. n EFFECT: ability to assess the effectiveness of antiviral drugs against influenza. n 2 dwg, 3 tbl, 4 ex |
| priorityDate | 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 213.